fed state

OTHER3 trials

Sponsors

Vanderbilt University, Icahn School of Medicine at Mount Sinai

Conditions

Bulimia NervosaCognitive Impairment

Phase 1

Putative Cognitive Enhancer VU319

CompletedNCT03220295

Vanderbilt UniversityCognitive Impairment

Start: 2017-07-28End: 2019-10-30Updated: 2020-02-06

Unknown Phase

Self-Control in Bulimia Nervosa

CompletedNCT04409457

Icahn School of Medicine at Mount SinaiBulimia Nervosa

Start: 2020-09-18End: 2024-11-05Updated: 2026-02-06

Changes in Inhibition and Valuation After Eating

RecruitingNCT05995496

Icahn School of Medicine at Mount SinaiBulimia Nervosa

Start: 2023-12-12End: 2027-12-31Target: 150Updated: 2026-02-17

Related Papers

Discovery of VU0467319: an M<sub>1</sub> Positive Allosteric Modulator Candidate That Advanced into Clinical Trials

ACS Chemical Neuroscience2024-12-119 citations